Methylenetetrahydrofolate dehydrogenase 1 deficiency
Methylenetetrahydrofolate dehydrogenase 1 deficiency (MTHFD1 deficiency) is a disease resulting from mutations of the MTHFD1 gene. Patients with this disease may have hemolytic uremic syndrome, macrocytosis, epilepsy, hearing loss, retinopathy, mild mental retardation, lymphocytopenia (involving all subsets) and low T-cell receptor excision circles.
History[edit]
The disease was first described by Watkins et al. in 2011.[1]
Alternative names[edit]
- Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH)
External links[edit]
- Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia (CIMAH) - a record in OMIM
References[edit]
- ^ Watkins D, Schwartzentruber JA, Ganesh J, Orange JS, Kaplan BS, Nunez LD, Majewski J, Rosenblatt DS (September 2011). "Novel inborn error of folate metabolism: identification by exome capture and sequencing of mutations in the MTHFD1 gene in a single proband". Journal of Medical Genetics. 48 (9): 590–2. doi:10.1136/jmedgenet-2011-100286. PMID 21813566. S2CID 9623450.
 | This genetic disorder article is a stub. You can help Wikipedia by expanding it. |